Prescripción potencialmente inapropiada en adultos mayores en México
Autor(a) principal: | |
---|---|
Data de Publicação: | 2021 |
Outros Autores: | , , , , , |
Tipo de documento: | Artigo |
Idioma: | spa eng |
Título da fonte: | Revista de Saúde Pública |
Texto Completo: | https://www.revistas.usp.br/rsp/article/view/193668 |
Resumo: | OBJETIVE: To identify and quantify potentially inappropriate prescribing (prescripción potencialmente inapropiada, PPI) and other drug prescribing problems in public health care services in a population-based study at the three existing levels of complexity in Mexico. METHODS Descriptive analysis of the Study on Satisfaction of Users of the Social Protection System in Health 2014–2016, prescription and drug supply section, to obtain the prevalence of PPI in older adults (≥ 65 years), based on Beers, STOPP, Prescrire and BSP listings using AM (older adults) prescription indicators, one for each listing. RESULTS Most older adults (67%) were prescribed at least one medication, with a mean of 2.7 medications per prescription. The PPI prevalence was 74% according to the BSP criteria, 67% according to the STOPP listing, 59% with the Beer criteria, and 20% with Prescrire. The most frequent PPI prescriptions were NSAIDs, vasodilators and sulfonylureas. CONCLUSIONS The use of PPIs in AM is high in Mexico. The higher prevalence found in this study may reflect the use of a source with population representativeness. The partial use and adaptations of the criteria make difficult comparing the studies; however, the STOPP criteria are the ones with the highest prevalence, as they cover a greater number of drugs and their use is more common in the first level of care. |
id |
USP-23_52016fcdddc04d5912fd18cb2a37b275 |
---|---|
oai_identifier_str |
oai:revistas.usp.br:article/193668 |
network_acronym_str |
USP-23 |
network_name_str |
Revista de Saúde Pública |
repository_id_str |
|
spelling |
Prescripción potencialmente inapropiada en adultos mayores en MéxicoPotentially inappropriate prescribing in older adults in MexicoOld personInappropriate PrescribingComorbidityMisuse of Prescription DrugsMedication-Related Side Effects and Adverse ReactionsAncianoPrescripción InadecuadaComorbilidadMal Uso de Medicamentos de Venta con RecetaEfectos Colaterales y Reacciones Adversas Relacionados con MedicamentosOBJETIVE: To identify and quantify potentially inappropriate prescribing (prescripción potencialmente inapropiada, PPI) and other drug prescribing problems in public health care services in a population-based study at the three existing levels of complexity in Mexico. METHODS Descriptive analysis of the Study on Satisfaction of Users of the Social Protection System in Health 2014–2016, prescription and drug supply section, to obtain the prevalence of PPI in older adults (≥ 65 years), based on Beers, STOPP, Prescrire and BSP listings using AM (older adults) prescription indicators, one for each listing. RESULTS Most older adults (67%) were prescribed at least one medication, with a mean of 2.7 medications per prescription. The PPI prevalence was 74% according to the BSP criteria, 67% according to the STOPP listing, 59% with the Beer criteria, and 20% with Prescrire. The most frequent PPI prescriptions were NSAIDs, vasodilators and sulfonylureas. CONCLUSIONS The use of PPIs in AM is high in Mexico. The higher prevalence found in this study may reflect the use of a source with population representativeness. The partial use and adaptations of the criteria make difficult comparing the studies; however, the STOPP criteria are the ones with the highest prevalence, as they cover a greater number of drugs and their use is more common in the first level of care.OBJETIVO: Identificar y cuantificar la prescripción potencialmente inapropiada (PPI) y otros problemas en la prescripción de medicamentos en los servicios públicos de atención médica en un estudio poblacional en los tres niveles de complejidad existentes en México. MÉTODOS: Análisis descriptivo del Estudio de Satisfacción de Usuarios del Sistema de Protección Social en Salud 2014–2016, sección de prescripción y surtimiento de medicamentos, para obtener la prevalencia de PPI en adultos mayores (≥ 65 años) con base en listados Beers, STOPP, Prescrire y BSP mediante indicadores de prescripción en AM, uno por cada listado. RESULTADOS: Al 67% de los AM se les prescribió al menos un medicamento, con una media de 2.7 medicamentos por receta. La prevalencia de PPI fue del 74% según los criterios BSP, del 67% según el listado STOPP, del 59% con los criterios Beer y del 20% con Prescrire. Las prescripciones PPI más frecuentes fueron los AINES, vasodilatadores y las sulfonilureas. CONCLUSIONES: El uso de PPI en AM es alto en México. La mayor prevalencia encontrada en este estudio puede ser reflejo de la utilización de una fuente con representatividad poblacional. La utilización parcial y adaptaciones de los criterios dificultan la comparabilidad entre estudios, sin embargo, los criterios STOPP son los que más altas prevalencias han presentado debido a que abarca un mayor número de medicamentos y su uso más habitual en el primer nivel de atenciónUniversidade de São Paulo. Faculdade de Saúde Pública2021-11-22info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfapplication/pdftext/xmlhttps://www.revistas.usp.br/rsp/article/view/19366810.11606/s1518-8787.20210550033110Revista de Saúde Pública; Vol. 55 (2021); 80Revista de Saúde Pública; Vol. 55 (2021); 80Revista de Saúde Pública; v. 55 (2021); 801518-87870034-8910reponame:Revista de Saúde Públicainstname:Universidade de São Paulo (USP)instacron:USPspaenghttps://www.revistas.usp.br/rsp/article/view/193668/178770https://www.revistas.usp.br/rsp/article/view/193668/178769https://www.revistas.usp.br/rsp/article/view/193668/178768Copyright (c) 2021 Pedro Jesús Saturno-Hernández, Ofelia Poblano-Verástegui, Omar Acosta-Ruiz, Arturo Cuauhtémoc Bautista-Morales, Patricia María Gómez-Cortez, José Luis Alcántara-Zamora, Luis Miguel Gutiérrez-Robledohttp://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessSaturno-Hernández, Pedro JesúsPoblano-Verástegui, OfeliaAcosta-Ruiz, OmarBautista-Morales, Arturo CuauhtémocGómez-Cortez, Patricia MaríaAlcántara-Zamora, José Luis Gutiérrez-Robledo, Luis Miguel2021-12-21T18:47:36Zoai:revistas.usp.br:article/193668Revistahttps://www.revistas.usp.br/rsp/indexONGhttps://www.revistas.usp.br/rsp/oairevsp@org.usp.br||revsp1@usp.br1518-87870034-8910opendoar:2021-12-21T18:47:36Revista de Saúde Pública - Universidade de São Paulo (USP)false |
dc.title.none.fl_str_mv |
Prescripción potencialmente inapropiada en adultos mayores en México Potentially inappropriate prescribing in older adults in Mexico |
title |
Prescripción potencialmente inapropiada en adultos mayores en México |
spellingShingle |
Prescripción potencialmente inapropiada en adultos mayores en México Saturno-Hernández, Pedro Jesús Old person Inappropriate Prescribing Comorbidity Misuse of Prescription Drugs Medication-Related Side Effects and Adverse Reactions Anciano Prescripción Inadecuada Comorbilidad Mal Uso de Medicamentos de Venta con Receta Efectos Colaterales y Reacciones Adversas Relacionados con Medicamentos |
title_short |
Prescripción potencialmente inapropiada en adultos mayores en México |
title_full |
Prescripción potencialmente inapropiada en adultos mayores en México |
title_fullStr |
Prescripción potencialmente inapropiada en adultos mayores en México |
title_full_unstemmed |
Prescripción potencialmente inapropiada en adultos mayores en México |
title_sort |
Prescripción potencialmente inapropiada en adultos mayores en México |
author |
Saturno-Hernández, Pedro Jesús |
author_facet |
Saturno-Hernández, Pedro Jesús Poblano-Verástegui, Ofelia Acosta-Ruiz, Omar Bautista-Morales, Arturo Cuauhtémoc Gómez-Cortez, Patricia María Alcántara-Zamora, José Luis Gutiérrez-Robledo, Luis Miguel |
author_role |
author |
author2 |
Poblano-Verástegui, Ofelia Acosta-Ruiz, Omar Bautista-Morales, Arturo Cuauhtémoc Gómez-Cortez, Patricia María Alcántara-Zamora, José Luis Gutiérrez-Robledo, Luis Miguel |
author2_role |
author author author author author author |
dc.contributor.author.fl_str_mv |
Saturno-Hernández, Pedro Jesús Poblano-Verástegui, Ofelia Acosta-Ruiz, Omar Bautista-Morales, Arturo Cuauhtémoc Gómez-Cortez, Patricia María Alcántara-Zamora, José Luis Gutiérrez-Robledo, Luis Miguel |
dc.subject.por.fl_str_mv |
Old person Inappropriate Prescribing Comorbidity Misuse of Prescription Drugs Medication-Related Side Effects and Adverse Reactions Anciano Prescripción Inadecuada Comorbilidad Mal Uso de Medicamentos de Venta con Receta Efectos Colaterales y Reacciones Adversas Relacionados con Medicamentos |
topic |
Old person Inappropriate Prescribing Comorbidity Misuse of Prescription Drugs Medication-Related Side Effects and Adverse Reactions Anciano Prescripción Inadecuada Comorbilidad Mal Uso de Medicamentos de Venta con Receta Efectos Colaterales y Reacciones Adversas Relacionados con Medicamentos |
description |
OBJETIVE: To identify and quantify potentially inappropriate prescribing (prescripción potencialmente inapropiada, PPI) and other drug prescribing problems in public health care services in a population-based study at the three existing levels of complexity in Mexico. METHODS Descriptive analysis of the Study on Satisfaction of Users of the Social Protection System in Health 2014–2016, prescription and drug supply section, to obtain the prevalence of PPI in older adults (≥ 65 years), based on Beers, STOPP, Prescrire and BSP listings using AM (older adults) prescription indicators, one for each listing. RESULTS Most older adults (67%) were prescribed at least one medication, with a mean of 2.7 medications per prescription. The PPI prevalence was 74% according to the BSP criteria, 67% according to the STOPP listing, 59% with the Beer criteria, and 20% with Prescrire. The most frequent PPI prescriptions were NSAIDs, vasodilators and sulfonylureas. CONCLUSIONS The use of PPIs in AM is high in Mexico. The higher prevalence found in this study may reflect the use of a source with population representativeness. The partial use and adaptations of the criteria make difficult comparing the studies; however, the STOPP criteria are the ones with the highest prevalence, as they cover a greater number of drugs and their use is more common in the first level of care. |
publishDate |
2021 |
dc.date.none.fl_str_mv |
2021-11-22 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://www.revistas.usp.br/rsp/article/view/193668 10.11606/s1518-8787.20210550033110 |
url |
https://www.revistas.usp.br/rsp/article/view/193668 |
identifier_str_mv |
10.11606/s1518-8787.20210550033110 |
dc.language.iso.fl_str_mv |
spa eng |
language |
spa eng |
dc.relation.none.fl_str_mv |
https://www.revistas.usp.br/rsp/article/view/193668/178770 https://www.revistas.usp.br/rsp/article/view/193668/178769 https://www.revistas.usp.br/rsp/article/view/193668/178768 |
dc.rights.driver.fl_str_mv |
http://creativecommons.org/licenses/by/4.0 info:eu-repo/semantics/openAccess |
rights_invalid_str_mv |
http://creativecommons.org/licenses/by/4.0 |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf application/pdf text/xml |
dc.publisher.none.fl_str_mv |
Universidade de São Paulo. Faculdade de Saúde Pública |
publisher.none.fl_str_mv |
Universidade de São Paulo. Faculdade de Saúde Pública |
dc.source.none.fl_str_mv |
Revista de Saúde Pública; Vol. 55 (2021); 80 Revista de Saúde Pública; Vol. 55 (2021); 80 Revista de Saúde Pública; v. 55 (2021); 80 1518-8787 0034-8910 reponame:Revista de Saúde Pública instname:Universidade de São Paulo (USP) instacron:USP |
instname_str |
Universidade de São Paulo (USP) |
instacron_str |
USP |
institution |
USP |
reponame_str |
Revista de Saúde Pública |
collection |
Revista de Saúde Pública |
repository.name.fl_str_mv |
Revista de Saúde Pública - Universidade de São Paulo (USP) |
repository.mail.fl_str_mv |
revsp@org.usp.br||revsp1@usp.br |
_version_ |
1800221802471882752 |